Our goal is to bring multiple therapeutics to the clinic for rare AND Infectious diseases


Collaborations Pharmaceuticals, Inc. performs research and development on innovative therapeutics for multiple rare and infectious diseases. We partner with academics or companies to identify and translate early preclinical to clinical stage assets. 

Current preclinical assets include those for Tuberculosis, Chagas, HIV, Batten Disease, HNPP - contact us for more details.

We have developed Assay Central which enables the curation of structure activity data and generation of machine learning models to facilitate this work - Try it here.

Talk to us about our rare disease research capabilities.



Funded by:



Find out about our mission.

Learn More →